Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial - results of the VA Cooperative Study #359 (abstract)

Author： Andriole G.L.   Guess H.A.   Epstein J.I.   Wise H.   Kadmon D.   Crawford E.D.   Hudson P.   Jackson C.L.   Romas N.A.   Patterson L.   Cook T.J.   Waldstreicher J.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.52, Iss.2, 1998-08, pp. : 195-202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? - results of a randomized, double-blind, placebo-controlled clinical trial

By Yang X.J.   Lecksell K.   Short K.   Gottesman J.   Peterson L.   Bannow J.   Schellhammer P.F.   Fitch W.P.   Hodge G.B.   Parra R.   Rouse S.   Waldstreicher J.   Epstein J.I.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 696-700

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo

By Roehrborn C.G.   Boyle P.   Bergner D.   Gray T.   Gittelman M.   Shown T.   Melman A.   Bracken R.B.   deVere White R.   Taylor A.   Wang D.   Waldstreicher J.   for the PLESS Study Group  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 662-669

Elsevier

Access to resources Recommend Favorite

Long-term effects of finasteride on prostate tissue composition - results of a four-year placebo-controlled trial (abstract)

By Marks L.S.   Partin A.W.   Dorey F.J.   Gormley G.J.   Epstein J.I.   Garris J.B.   Macairan M.L.   Shery E.D.   Santos P.B.   Stoner E.   deKernion J.B.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 574-580

Elsevier

Access to resources Recommend Favorite

Comparison of different prostate-specific antigen cutpoints for early detection of prostate cancer:results of a large screening study

By Reissigl A.   Pointner J.   Horninger W.   Ennemoser O.   Strasser H.   Klocker H.   Bartsch G.  

Urology, Vol. 46, Iss. 5, 1995-11 ,pp. : 662-665

Elsevier

Access to resources Recommend Favorite

Minimal time to successful intercourse after sildenafil citrate: results of a randomized, double-blind, placebo-controlled trial

By Padma-Nathan H.   Stecher V.J.   Sweeney M.   Orazem J.   Tseng L.-J.   deriesthal H.  

Urology, Vol. 62, Iss. 3, 2003-09 ,pp. : 400-403

Elsevier

Access to resources Recommend Favorite